Wolfgang M Schmidt

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. ncbi In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model
    Wolfgang M Schmidt
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
    Pharmacogenet Genomics 18:109-20. 2008
  2. ncbi In vivo profile of the human leukocyte microRNA response to endotoxemia
    Wolfgang M Schmidt
    Department of Clinical Pharmacology, Division of Pharmacogenetics and Imaging, Medical University of Vienna, A 1090 Vienna, Austria
    Biochem Biophys Res Commun 380:437-41. 2009
  3. ncbi Ramipril modulates circadian gene expression in skeletal muscle
    Robert Sauermann
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
    Pharmacogenet Genomics 21:751-9. 2011
  4. ncbi Forearm vasodilator reactivity in homozygous carriers of the 9p21.3 rs1333049 G>C polymorphism
    Stefan Aschauer
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
    Eur J Clin Invest 40:700-5. 2010
  5. ncbi Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling
    Wolfgang M Schmidt
    VBC-GENOMICS Bioscience Research Inc, Vienna, Austria
    Int J Cancer 112:200-12. 2004
  6. ncbi Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody
    Christine Hafner
    Department of Dermatology, Division of General Dermatology, Medical University of Vienna, Vienna, Austria
    Int J Cancer 114:426-32. 2005
  7. ncbi Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells
    Gerwin Heller
    Division of Oncology, Department of Medicine I, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Cancer Res 68:44-54. 2008

Collaborators

Detail Information

Publications7

  1. ncbi In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model
    Wolfgang M Schmidt
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
    Pharmacogenet Genomics 18:109-20. 2008
    ..To gain insight into molecular mechanisms of anti-inflammatory effects of statins, we have studied global gene expression in circulating leucocytes in an in-vivo model of acute inflammation following statin administration...
  2. ncbi In vivo profile of the human leukocyte microRNA response to endotoxemia
    Wolfgang M Schmidt
    Department of Clinical Pharmacology, Division of Pharmacogenetics and Imaging, Medical University of Vienna, A 1090 Vienna, Austria
    Biochem Biophys Res Commun 380:437-41. 2009
    ..The miRNAs and their potential target genes identified herein contribute to the understanding of the complex transcriptional program of innate immunity initiated by pathogens...
  3. ncbi Ramipril modulates circadian gene expression in skeletal muscle
    Robert Sauermann
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
    Pharmacogenet Genomics 21:751-9. 2011
    ..To identify these mechanisms, we studied the effect of ACE-inhibition on gene expression in skeletal muscle, a primary target tissue for insulin in glucose homeostasis...
  4. ncbi Forearm vasodilator reactivity in homozygous carriers of the 9p21.3 rs1333049 G>C polymorphism
    Stefan Aschauer
    Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
    Eur J Clin Invest 40:700-5. 2010
    ..The aim of the present case-control study was to test whether this chromosome 9p21.3 locus, represented by the rs1333049 variant, is associated with altered vasodilator resistance vessel function in healthy young volunteers...
  5. ncbi Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling
    Wolfgang M Schmidt
    VBC-GENOMICS Bioscience Research Inc, Vienna, Austria
    Int J Cancer 112:200-12. 2004
    ..This study emphasizes the understanding of resistance as a time-depending process: the cell is particularly challenged at the beginning of this process, while acquisition of the high-resistance phenotype seems to be less demanding...
  6. ncbi Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody
    Christine Hafner
    Department of Dermatology, Division of General Dermatology, Medical University of Vienna, Vienna, Austria
    Int J Cancer 114:426-32. 2005
    ..28S. Our results suggest that anti-HMW-MAA mAbs may represent useful reagents to apply passive immunotherapy to patients with malignant melanoma...
  7. ncbi Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells
    Gerwin Heller
    Division of Oncology, Department of Medicine I, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Cancer Res 68:44-54. 2008
    ....